 | M&A drug wars |
March-1-2018
| Lawyer | Neill May |
| Area | Mergers and Acquisitions |
Summary
Article originally published in the Canadian Lawyer Magazine, March 2018
Excerpt from "M&A drug wars":
The dispute that resulted from the unsolicited bid by Aurora Canada Inc. for CanniMed Therapeutics Inc. (which ultimately resulted in a consensual deal) was, therefore, in a general sense, predictable. The clash was also much watched as the first “poison pill” decision by Canadian securities regulators in the wake of the significant reforms to the rules governing takeover bids in 2016 and a high-profile test of some core elements of the new rules.
